Mustang Bio, INC DEF 14A proxy statements

Mustang Bio, Inc. is calling its stockholders to a virtual Annual Meeting on December 22, 2025, to vote on director elections, auditor ratification, and significant increases to its employee stock purchase and incentive plans.

Mustang Bio's majority stockholders approved the issuance of up to 5,475,082 common shares underlying outstanding warrants to comply with Nasdaq Listing Rule 5635(d).

Mustang Bio informs stockholders of the approval of a warrant share issuance by majority holders via written consent, aimed at complying with Nasdaq listing rules.

Mustang Bio will hold its annual stockholders meeting virtually on December 26, 2024, to elect directors and ratify the appointment of its accounting firm.

Mustang Bio stockholders have approved the issuance of shares underlying certain warrants and a reverse stock split to be implemented at the Board's discretion before June 27, 2025.